Related Experiment Video
Updated: May 24, 2026

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
[Mould and mycotoxin contamination of medicinal materials]
1Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Institute of Medicinal Plant Development, Peking Union Medical College, Beijing 100193, China.
Abstract:
Medicinal materials may be contaminated with a broad variety of fungi, which are represented by Aspergillus spp, Penlicillium spp, Fusarium spp, Rhizopus spp, Mucor spp et al. This fact limits the utilization of medicinal materials, besides, medicinal materials may also be contaminated with mycotoxins produced by these fungi, and bring harm to human health. Several mycotoxins have been detected in medicinal materials, such as AFTs, OTA, FBs, et al. The contamination may originate from the conditions in which the medicinal plants are cultivated, stored and in the finished product manufacturing stages. Some methods have been used for detoxifcation and disinfection for medicinal materials, but they have limited effects. Taking into consideration the background situation, it is important for medicinal materials to be protected from contamination of fungi at every stage of production. The present study intends to give a review of contamination of medicinal materials by moulds and mycotoxins and discuss the factors influencing this situation, expecting to contribute to the knowledge for reducing the contamination.
Insights
Medicinal materials can be contaminated by fungi and harmful mycotoxins, impacting their use and human health. This review examines contamination sources and influencing factors to improve protection strategies.
Area of Science:
- Mycology
- Food Science
- Pharmacognosy
Context:
- Medicinal materials are susceptible to contamination by diverse fungal species, including Aspergillus, Penicillium, and Fusarium.
- Fungal contamination leads to the presence of mycotoxins (e.g., aflatoxins, ochratoxins, fumonisins), posing risks to human health.
- Contamination occurs throughout cultivation, storage, and manufacturing, limiting the efficacy and safety of medicinal products.
Purpose:
- To review the prevalence of fungal and mycotoxin contamination in medicinal materials.
- To identify factors contributing to fungal and mycotoxin contamination.
- To highlight the need for effective contamination control strategies throughout the production chain.
Summary:
- Fungi like Aspergillus spp. and Penicillium spp. contaminate medicinal materials, producing toxic compounds such as aflatoxins (AFTs), ochratoxins (OTA), and fumonisins (FBs).
- Contamination sources include agricultural practices, post-harvest storage, and manufacturing processes.
- Current disinfection methods show limited efficacy, necessitating a focus on preventative measures.
Impact:
- Enhances understanding of fungal and mycotoxin risks in medicinal materials.
- Provides a basis for developing improved quality control and safety protocols.
- Contributes to safeguarding public health by ensuring the integrity of medicinal resources.
Related Concept Videos
Fungal Group Zygomycota
Microbial Spoilage of Food
Microbes in the Production of Fermented Foods
Fungal Phylum Basidiomycota
Fungal Phylum Ascomycota
Biodeterioration
